BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/8/2014 4:45:00 PM | Browse: 1166 | Download: 1281
 |
Received |
|
2014-02-27 21:12 |
 |
Peer-Review Started |
|
2014-02-28 17:14 |
 |
To Make the First Decision |
|
2014-03-27 10:55 |
 |
Return for Revision |
|
2014-04-02 20:52 |
 |
Revised |
|
2014-04-03 10:47 |
 |
Second Decision |
|
2014-10-27 16:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-10-27 17:01 |
 |
Articles in Press |
|
2014-10-27 17:01 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-11-06 08:26 |
 |
Publish the Manuscript Online |
|
2014-12-08 16:44 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics
|
Manuscript Source |
Invited Manuscript |
All Author List |
Amosy E M’Koma |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
NIH |
R21DK095168 |
NIH |
U54MD007593 |
NIH |
UL1TR000445 |
|
Corresponding Author |
Amosy E M’Koma, MD, MS, PhD, Assistant Professor of Surgery, Biochemistry and Cancer Biology, Department of Biochemistry and Cancer Biology, Meharry Medical College School of Medicine, 1005 Dr. D. B. Todd Jr. Blvd., Nashville, TN 37208-3599, United States. amkoma@mmc.edu |
Key Words |
Inflammatory bowel disease; Diagnosis; Advances and challenges; MALDI-MS/IMS; Molecular biometrics; Immunometrics |
Core Tip |
Pouch surgery (the restorative proctocolectomy and ileal pouch-anal anastomosis for the curative surgical treatment of ulcerative colitis and familial adenomatous polyposis) replaces the colon and rectum after proctocolectomy with a pouch constructed from the distal small bowel (ileum) and sutured to the anal canal above the dentate/pectinate line preserving the anal sphincters. The operation restores gut continuity, defecation, deferral, and discrimination, if the diagnosis is correct, which is unpredictable in 30% of the colonic-inflammatory bowel disease-patients. Mass spectrometry and imaging mass spectrometry are groundbreaking, non-invasive analytical technologies with the ability to directly measure individual molecular species in complex clinical specimens. These technologies provide quantitative and qualitative analysis of cellular systems, and allow differentiation between disease and normal molecules from the same organ. These characteristics offer diagnostic and prognostic value for clinical medicine. |
Publish Date |
2014-12-08 16:44 |
Citation |
M’Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg 2014; 6(11): 208-219 |
URL |
http://www.wjgnet.com/1948-9366/full/v6/i11/208.htm |
DOI |
http://dx.doi.org/10.4240/wjgs.v6.i11.208 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345